Navigation Links
Children and teenagers at risk for noise-induced hearing loss, warn America's ENT doctors
Date:4/30/2009

(Alexandria, VA) Children and teenagers are frequently exposed to potentially damaging noise levels in schools, at home, and in sports, but there has been little reported on their risk for noise-induced hearing loss. In fact, three million children under the age of 18 have some hearing loss, and one factor is external noises.

A recent survey by the American Academy of Otolaryngology Head and Neck Surgery (AAO - HNS), which represents ear, nose and throat doctors, found that 4 in 5 Americans are concerned about hearing loss due to ear buds. The survey showed that hearing loss is a top medical concern among parents, higher than concerns about asthma, food allergies, or exposure to tobacco smoke. More than 90 percent of parents are very concerned about hearing loss in their children.

Nationwide, 10 million Americans suffer from irreversible noise-induced hearing loss, with 30 million more exposed to dangerous noise levels each day. For children and teenagers, one of the simplest and most preventable ways that they can acquire noise-induced hearing loss is by listening to loud music.

"It's important to be aware of the intensity of sound around you in order to protect your hearing," said Marcella Bothwell, MD, a pediatric otolaryngologist--head and neck surgeon at Rady Children's Hospital in San Diego, CA, and chair of the AAO-HNS Board of Governors public relations committee. "Children and teenagers are not always able to recognize when surrounding noises have reached dangerous levels, and that's why parents and caretakers need to be aware, in order to teach them how to avoid permanent damage."

In recognition of Better Hearing and Speech Month, which is celebrated in May, the AAO-HNS recommends these tips to ensure that parents know how to protect their families from noise-induced hearing loss:

Encourage your children to take breaks from long periods of listening to music. Give your child ear plugs or ear muffs if
'/>"/>

Contact: Jessica Mikulski
newsroom@entnet.org
703-535-3762
American Academy of Otolaryngology -- Head and Neck Surgery
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Video: CVS Caremark Charitable Trust Awards $4.2 Million in Grants Benefiting Children with Disabilities, Uninsured
2. Wayne State University and Childrens Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder
3. TeleHealth Services and UNC-TV Partner to Bring Kids Channel to North Carolina Children's Hospitals
4. Hopkins Childrens study: Folic acid may help treat allergies, asthma
5. Goldie Hawn and Youth from Across the Country to Join SAMHSA in a Celebration of Childrens Mental Health
6. Tracee Ellis Ross, NancyJane Goldston & Vicki Martin to be Honored by Aviva Family and Childrens Services at The A Party
7. Pennsylvania Secretary of Health Reminds All Parents to Be Wise, Immunize Your Children
8. Children Emerge as Winners in Twitter Challenge Between Ashton Kutcher and CNN
9. Free Health, Dental and Vision Screenings at Hamilton Health Center on May 2 Will Help Harrisburg Area Children and Adults
10. Light of Hope: Help for Children with Autism Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders
11. Learning and Moving, a GeoFitness Solution for Preventing Obesity in Children and Increasing School Success

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Constraint-induced movement therapy (CIMT) is a po...ren with hemiplegic cerebral palsy, but more resea...w published in the November issue of Physical The...n Physical Therapy Association (APTA). The review,...ematic reviews, concluded that further research sh...
(Date:12/2/2009)... Revolutionary new cell phones that direct ...l be available in early 2010 from Aerius Internati...mber 2, 2009 -- Revolutionary new cell phones that...sers will be available in early 2010 from Aerius I...red with a Green Technology Award in wireless comm...
(Date:12/2/2009)... A team of Kendall Hunt authors earned the ...d at the recent National Association for Gifted Ch...ember 5-7, 2009. , Dubuqu...l Hunt authors earned the 2009 Gifted Child Quarte... Association for Gifted Children’s annual co...
(Date:12/2/2009)...HINGTON, Dec. 2 Pro-abo..., December 2 in their campaign against the U.S. Ho... Americans United for Life President and CEO Charm...the abortion lobby,s effort to expand taxpayer fun...h health care, the feminist groups and the abortio...
(Date:12/2/2009)...S ANGELES, Dec. 2 At a ...Tourism ministerial delegates came together to out...equired to give it the necessary thrust. Organized...edicaltourismassociation.com , the high-powered co...iscussed the opportunities and requests for assist...
Breaking Medicine News(10 mins):Health News:Report shows CIMT may improve arm use in children with hemiplegic cerebral palsy 2Health News:New AERIUS Cell Phones Direct Microwave Signals Away from Users 2Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3
...A hospital in Chennai has created history by succe...ant in an eight-year-old Ugandan boy using the co...on of what the procedure would cost internationall...ht to the Apollo Specialty Hospital here. ...
...Three gene variants in the DNA of 486 AIDS patient...the HIV virus, according to research published Th... will lead to a vaccine that would boost the prote...mising, the scientists said in a study to appear i...
...A British woman will be aiming to raise awareness ...y when she sets out on a solo row across the Pacif...Roz Savage, 38, has already traversed the Atlantic... across the vast expanse of the Pacific. S...
...Madrid is the culinary melting pot of a country wh...rld by the New York Times, the author of a new boo...here is no real Madrid cooking but that's because ...novative cooking in Madrid). Rincon came u...
...Supermodel Petra Nemcova turned vegetarian to help...gave up meat and dairy products in February after ... "I read that if we fish the way we fish, ... star insisted that that she felt a 'strong connec...
...Burlesque star Dita Von Teese says that she often ... healthy hobby to be a voyeur. The estran...ur pornography has something to offer to almost ev... She insists that she is just like other people ...
Other Medicine News:Health News:Chennai Hospital Conducts Bone Marrow Transplantation Successfully 2Health News:Three Gene Variants Could Hold Key for HIV Vaccine: Study 2Health News:Briton Set for Pacific Solo Odyssey to Highlight Warming 2
(Date:12/2/2009)... , PLEASANTON, Calif., Dec. 2 /PRNewswire-Firs...nced today that the United States Food & Drug ...ed use for its licensed nucleic acid test, to scre...dividual donations. The test, called the cobas... system, is a qualitative, in-vitro test for the s...
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire-...r the "Company") (NYSE: SCR ), a leading pharmac...anufacturing, and marketing of branded,generic and...ted that its,subsidiary Jiangsu Yanshen Biological...s suspended production of all its products in orde...
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 /PRNewsw...cluding a late-breaking presentation on Tasigna...ic myeloid leukemia, demonstrate the strength of t... care of patients. ,, The new data, at the 51s...ing and Exposition, highlight the company,s curren...
Breaking Medicine Technology:FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 2FDA Approves Use of Roche Test to Screen Source Plasma for HIV, Hepatitis B Virus and Hepatitis C Virus 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Brain computer interface developed at Brown begins new clinical trial 8783 1Brain computer interface developed at Brown begins new clinical trial 8783 2Brain computer interface developed at Brown begins new clinical trial 8783 3Brain computer interface developed at Brown begins new clinical trial 8783 4Published Study Shows VNUS ClosureFAST 26amp 3B 238482 3B System Significantly Superior to Laser for Varicose Vein Treatment 48411 1Published Study Shows VNUS ClosureFAST 26amp 3B 238482 3B System Significantly Superior to Laser for Varicose Vein Treatment 48411 2Published Study Shows VNUS ClosureFAST 26amp 3B 238482 3B System Significantly Superior to Laser for Varicose Vein Treatment 48411 3Forterus Inc Announces Special Board Meeting 3B Nominates Jeff Walton Former Bear Stearns President to Board of Directors 48408 1Forterus Inc Announces Special Board Meeting 3B Nominates Jeff Walton Former Bear Stearns President to Board of Directors 48408 2
...nces announced,today, the initiation of a Phase 2 ...he treatment and management of acute infectious,mo...apeutics for the,treatment for this debilitating c...n-Barr virus (EBV), "Valomaciclovir has shown a b...ibition of viral replication of herpes zoster and ...
...gel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) today a... PFE ), has begun a Phase 1 clinical trial of an,...kinase inhibitor, R343,for the treatment of allerg...Rigel,s clinical portfolio., Under the terms of t...will receive a $5 million milestone payment from P...
Other Medicine Technology:Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
Alloclassic Hip
Perfecta RS Stems
S-ROM Femoral Stems - XX-Long Length Stems 36mm Neck with 21mm Calcar Replacement + Lat Neck
S-ROM Femoral Stems - Long Length Stems Standard 36mm Neck
Medicine Products: